Autoimmunity and pulmonary hypertension: a perspective

Area of Science:

• Immunology
• Cardiovascular Medicine
• Pulmonary Medicine

Background:

• The link between autoimmunity and pulmonary arterial hypertension (PAH) is known, but its specific role in disease development is unclear.
• Diverse conditions, including infections and connective tissue disorders, can lead to similar pulmonary vascular pathology.
• Regulatory T-cells' role in preventing B-cell overactivity is a potential unifying biological factor.

Purpose of the Study:

• To review autoimmune phenomena in PAH patients.
• To explore if loss of self-tolerance and subsequent autoimmune injury contribute to PAH pathogenesis.
• To investigate the connection between immune system defects and PAH development.

Main Methods:

• Review of existing literature on autoimmune diseases and PAH.
• Analysis of immune system defects, specifically CD4 T-cells and auto-antibody production, in conditions associated with severe pulmonary hypertension.
• Examination of the role of auto-antibodies in endothelial cell apoptosis.

Main Results:

• Conditions linked to severe angioproliferative pulmonary hypertension often show CD4 T-cell defects and auto-antibody production.
• Pathogenic auto-antibodies targeting endothelial cells can induce apoptosis, potentially initiating PAH.
• A loss of self-tolerance may precede autoimmune injury contributing to PAH.

Conclusions:

• Autoimmune processes, including auto-antibody production against endothelial cells, are implicated in PAH development.
• Defects in immune regulation, particularly involving T-cells, may play a crucial role.
• Further research into early self-tolerance loss could elucidate PAH's autoimmune origins.